Crystalloid Versus Hydroxyethyl Starch Trials

PHASE3CompletedINTERVENTIONAL
Enrollment

7,000

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

April 30, 2012

Study Completion Date

September 30, 2012

Conditions
Intensive Care
Interventions
DRUG

6% Hydroxy-ethyl starch (130/0.4)

Maximum dose of 50ml/kg/day of 6% hydroxy-ethyl starch (130/0.4) for intravascular volume fluid resuscitation

DRUG

Saline

Maximum dose of 50ml/kg/day of saline for intravascular volume fluid resuscitation

Trial Locations (1)

2000

The George Institute for International Health, Sydney

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Sydney

OTHER

collaborator

Australian and New Zealand Intensive Care Society Clinical Trials Group

NETWORK

collaborator

Fresenius Kabi

INDUSTRY

lead

The George Institute

OTHER